Your Article Summary
(Click the title below to leave the MDLinx Network and go to the Journal's Website)
GSK to drive growth in emerging markets with acquisition of UCB products
GlaxoSmithKline, 01/26/09
GlaxoSmithKline plc (GSK) announced that it has signed an agreement with UCB S.A to acquire its current marketed product portfolio across certain territories in Africa, the Middle East, Asia Pacific and Latin America, for a cash consideration of €515 million (£483 million.)
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Go Go Generics
PharmExec, 12/18/09
MediciNova and Avigen Stockholders Approve Merger
Avigen, 12/18/09
Almirall and Forest Laboratories to Expand Respiratory Collaboration with LAS100977
Forest Laboratories, 12/18/09
Article Search
Sponsor


See Latest Articles


